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Identity 
Other names: CGI-46; ECP51; INO80J; REPTIN; 
RVB2; Reptin52; Rvb2; TAP54-beta; TIH2; TIP48; 
TIP49B 




15 exons, 14 introns (Parfait et al., 2000). 
Transcription 
1518bp mRNA with 463aa open reading frame. 
Protein 
Description 
463 amino acids, 52 kDa. 
RUVBL2 belongs to the AAA+ ATPase super-family 
(ATPases associated with diverse cellular activities) 
sharing conserved Walker A and B motifs, arginine 
fingers, and sensor domains. The monomers contain 
two domains, which are involved in ATP binding and 
hydrolysis respectively. RUVBL2 assembles into an 
hexameric structure with a central channel. 
RUVBL2 interacts with RUVBL1 to form a dodecamer 
(Puri et al., 2007). This RUVBL1/ RUVBL2 complex 
displays a significant ATPase activity and is likely one 
of the functional forms of the proteins. Sumoylation of 
RUVBL2 has been reported on 
Lys456 in invasive prostate cancer cells (Kim et al., 
2006). 
RUVBL2 is phosphorylated on an ATM/ATR 
consensus site following DNA damage (Matsuoka et 
al., 2007). 
Expression 
Expression of RUVBL2 is ubiquitous but especially 
abundant in thymus and testis (Salzer et al., 1999; 
Parfait et al., 2000). 
RUVBL2 is overexpressed in hepatocellular carci-
noma (Rousseau et al., 2007). Overexpression of 
RUVBL2 in several cancers and its possible role in 
human cancers has been reported (reviewed in Huber et 
al., 2008). 
Localisation 
Cytoplasm and nucleus. 
Function 
RUVBL2 interacts with c-myc (Wood et al., 2000) and 
also modulates transcriptional regulation by the beta-
catenin/TCF-LEF complex (Bauer et al., 2000) and 
ATF2 (Cho et al., 2001). RUVBL2 participates in the 
remodelling of chromatin as a member of several 
complexes such as TIP60 (Ikura et al., 2000), INO80 
(Jin et al., 2005), SRCAP (Cai et al., 2005). 
It is also involved in transcriptional regulation 
(reviewed in Gallant, 2007), DNA repair (Gospodinov 
et al., 2008), snoRNP biogenesis (Watkins et al., 2002), 
and telomerase activity (Venteicher et al., 2008). 
RUVBL2 silencing in fibroblasts induces a senescent 
phenotype (Chan et al., 2005). 
Implicated in 
Hepatocellular carcinoma (HCC) 
Disease 
RUVBL2 was found to be overexpressed in 75% of 
cases in a series of 96 human HCC studied with real-
time RT-PCR (Rousseau et al., 2007). It was also 
increased in a smaller 15 cases series (Iizuka et al., 
2006). No mutations in the coding sequence were 
identified (Rousseau et al., 2007). 
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Prognosis 
Overexpression of RUVBL2 was an independent factor 
of poor prognosis (Rousseau et al., 2007). 
Oncogenesis 
RUVBL2 depletion with siRNAs led to HCC cell 
growth arrest and apoptosis, whereas over-expression 
in HCC cells allowed these cells to give rise to more 
progressive tumors in xenografts than control cells 
(Rousseau et al., 2007). 
Colon cancer 
Disease 
RUVBL2 was overexpressed in a series of 18 colon 
cancers (Graudens et al., 2006). 
Melanoma 
Disease 
RUVBL2 was overexpressed in a series of 45 
melanomas (Talantov et al., 2005). 
Bladder carcinoma 
Disease 
RUVBL2 was overexpressed in a series of 108 bladder 
carcinomas (Sanchez-Carbayo et al., 2006). 
Prostate cancer 
Oncogenesis 
In conjunction with beta-catenin, RUVBL2 represses 
the expression of the anti-metastasis gene KAI-1 (Kim 
et al., 2005) and is involved in the invasive phenotype 
of cultured prostate cancer cells (Kim et al., 2006). 
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